Skip to main content
JAMA Network logoLink to JAMA Network
. 2020 Jun 17;5(9):1071. doi: 10.1001/jamacardio.2020.2302

Errors in Abstract, Results, and End Matter

PMCID: PMC7301296  PMID: 32936256

The Brief Report “Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19),”1 published online on May 1, 2020, contained 3 errors. The first was a misstated percentage in the Abstract and Results. The phrase “3 patients (3%)” should have said “3 patients (8%).” In addition, a percentage in the Results section was missing a decimal point. The phrase “(26 patients [289%]…)” should have said “(26 patients [28.9%]…).” Finally, the Corresponding Author information for Howard S. Gold, MD, and Peter J. Zimetbaum, MD, was inadvertently omitted and has been added. The article has been corrected online.

References

  • 1.Mercuro NJ, Yen CF, Shim DJ, et al. . Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. Published online May 1, 2020. doi: 10.1001/jamacardio.2020.1834 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Cardiology are provided here courtesy of American Medical Association

RESOURCES